SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-042447
Filing Date
2015-06-01
Accepted
2015-06-01 16:01:36
Documents
2
Period of Report
2015-05-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-13279_18k.htm 8-K 26594
2 EX-99.1 a15-13279_1ex99d1.htm EX-99.1 32057
  Complete submission text file 0001104659-15-042447.txt   59764
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35921 | Film No.: 15903332
SIC: 2834 Pharmaceutical Preparations